Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Activated Clotting Time (ACT) Cartridge Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Activated Clotting Time (ACT) Cartridge Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-08-01

Pages: 78 Pages

Report ld: 4829842

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Activated Clotting Time (ACT) Cartridge market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Activated Clotting Time (ACT) Cartridge market competitiveness, regional economic performance, and supply chain configurations.

The North America Activated Clotting Time (ACT) Cartridge market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Activated Clotting Time (ACT) Cartridge include Medtronic, Abbott, Calbiotech, Anogen, Sienco, BioDee, Kanglang Biotechnology, X-Y Biotechnology, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Activated Clotting Time (ACT) Cartridge market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Medtronic
Abbott
Calbiotech
Anogen
Sienco
BioDee
Kanglang Biotechnology
X-Y Biotechnology

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Enzyme-linked Immunosorbent Assay
Coagulation Method
Others

Segment by Application

Hospital
Clinic
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Activated Clotting Time (ACT) Cartridge market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Coagulation Method in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Activated Clotting Time (ACT) Cartridge value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Activated Clotting Time (ACT) Cartridge Product Scope

1.2 Activated Clotting Time (ACT) Cartridge by Type

1.2.1 Global Activated Clotting Time (ACT) Cartridge Sales by Type (2020 & 2024 & 2031)

1.2.2 Enzyme-linked Immunosorbent Assay

1.2.3 Coagulation Method

1.2.4 Others

1.3 Activated Clotting Time (ACT) Cartridge by Application

1.3.1 Global Activated Clotting Time (ACT) Cartridge Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Activated Clotting Time (ACT) Cartridge Market Estimates and Forecasts (2020-2031)

1.4.1 Global Activated Clotting Time (ACT) Cartridge Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Activated Clotting Time (ACT) Cartridge Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Activated Clotting Time (ACT) Cartridge Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Activated Clotting Time (ACT) Cartridge Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Activated Clotting Time (ACT) Cartridge Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Region (2020-2025)

2.2.2 Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Region (2020-2025)

2.3 Global Activated Clotting Time (ACT) Cartridge Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Activated Clotting Time (ACT) Cartridge Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Activated Clotting Time (ACT) Cartridge Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Activated Clotting Time (ACT) Cartridge Market Size and Prospective (2020-2031)

2.4.2 Europe Activated Clotting Time (ACT) Cartridge Market Size and Prospective (2020-2031)

2.4.3 China Activated Clotting Time (ACT) Cartridge Market Size and Prospective (2020-2031)

2.4.4 Japan Activated Clotting Time (ACT) Cartridge Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Activated Clotting Time (ACT) Cartridge Historic Market Review by Type (2020-2025)

3.1.1 Global Activated Clotting Time (ACT) Cartridge Sales by Type (2020-2025)

3.1.2 Global Activated Clotting Time (ACT) Cartridge Revenue by Type (2020-2025)

3.1.3 Global Activated Clotting Time (ACT) Cartridge Price by Type (2020-2025)

3.2 Global Activated Clotting Time (ACT) Cartridge Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Activated Clotting Time (ACT) Cartridge Sales Forecast by Type (2026-2031)

3.2.2 Global Activated Clotting Time (ACT) Cartridge Revenue Forecast by Type (2026-2031)

3.2.3 Global Activated Clotting Time (ACT) Cartridge Price Forecast by Type (2026-2031)

3.3 Different Types Activated Clotting Time (ACT) Cartridge Representative Players

4 Global Market Size by Application

4.1 Global Activated Clotting Time (ACT) Cartridge Historic Market Review by Application (2020-2025)

4.1.1 Global Activated Clotting Time (ACT) Cartridge Sales by Application (2020-2025)

4.1.2 Global Activated Clotting Time (ACT) Cartridge Revenue by Application (2020-2025)

4.1.3 Global Activated Clotting Time (ACT) Cartridge Price by Application (2020-2025)

4.2 Global Activated Clotting Time (ACT) Cartridge Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Activated Clotting Time (ACT) Cartridge Sales Forecast by Application (2026-2031)

4.2.2 Global Activated Clotting Time (ACT) Cartridge Revenue Forecast by Application (2026-2031)

4.2.3 Global Activated Clotting Time (ACT) Cartridge Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Activated Clotting Time (ACT) Cartridge Application

5 Competition Landscape by Players

5.1 Global Activated Clotting Time (ACT) Cartridge Sales by Players (2020-2025)

5.2 Global Top Activated Clotting Time (ACT) Cartridge Players by Revenue (2020-2025)

5.3 Global Activated Clotting Time (ACT) Cartridge Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activated Clotting Time (ACT) Cartridge as of 2024)

5.4 Global Activated Clotting Time (ACT) Cartridge Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Activated Clotting Time (ACT) Cartridge, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Activated Clotting Time (ACT) Cartridge, Product Type & Application

5.7 Global Key Manufacturers of Activated Clotting Time (ACT) Cartridge, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Activated Clotting Time (ACT) Cartridge Sales by Company

6.1.1.1 North America Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025)

6.1.1.2 North America Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025)

6.1.2 North America Activated Clotting Time (ACT) Cartridge Sales Breakdown by Type (2020-2025)

6.1.3 North America Activated Clotting Time (ACT) Cartridge Sales Breakdown by Application (2020-2025)

6.1.4 North America Activated Clotting Time (ACT) Cartridge Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Activated Clotting Time (ACT) Cartridge Sales by Company

6.2.1.1 Europe Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025)

6.2.1.2 Europe Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025)

6.2.2 Europe Activated Clotting Time (ACT) Cartridge Sales Breakdown by Type (2020-2025)

6.2.3 Europe Activated Clotting Time (ACT) Cartridge Sales Breakdown by Application (2020-2025)

6.2.4 Europe Activated Clotting Time (ACT) Cartridge Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Activated Clotting Time (ACT) Cartridge Sales by Company

6.3.1.1 China Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025)

6.3.1.2 China Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025)

6.3.2 China Activated Clotting Time (ACT) Cartridge Sales Breakdown by Type (2020-2025)

6.3.3 China Activated Clotting Time (ACT) Cartridge Sales Breakdown by Application (2020-2025)

6.3.4 China Activated Clotting Time (ACT) Cartridge Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Activated Clotting Time (ACT) Cartridge Sales by Company

6.4.1.1 Japan Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025)

6.4.1.2 Japan Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025)

6.4.2 Japan Activated Clotting Time (ACT) Cartridge Sales Breakdown by Type (2020-2025)

6.4.3 Japan Activated Clotting Time (ACT) Cartridge Sales Breakdown by Application (2020-2025)

6.4.4 Japan Activated Clotting Time (ACT) Cartridge Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Medtronic

7.1.1 Medtronic Company Information

7.1.2 Medtronic Business Overview

7.1.3 Medtronic Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Medtronic Activated Clotting Time (ACT) Cartridge Products Offered

7.1.5 Medtronic Recent Development

7.2 Abbott

7.2.1 Abbott Company Information

7.2.2 Abbott Business Overview

7.2.3 Abbott Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Abbott Activated Clotting Time (ACT) Cartridge Products Offered

7.2.5 Abbott Recent Development

7.3 Calbiotech

7.3.1 Calbiotech Company Information

7.3.2 Calbiotech Business Overview

7.3.3 Calbiotech Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Calbiotech Activated Clotting Time (ACT) Cartridge Products Offered

7.3.5 Calbiotech Recent Development

7.4 Anogen

7.4.1 Anogen Company Information

7.4.2 Anogen Business Overview

7.4.3 Anogen Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Anogen Activated Clotting Time (ACT) Cartridge Products Offered

7.4.5 Anogen Recent Development

7.5 Sienco

7.5.1 Sienco Company Information

7.5.2 Sienco Business Overview

7.5.3 Sienco Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Sienco Activated Clotting Time (ACT) Cartridge Products Offered

7.5.5 Sienco Recent Development

7.6 BioDee

7.6.1 BioDee Company Information

7.6.2 BioDee Business Overview

7.6.3 BioDee Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.6.4 BioDee Activated Clotting Time (ACT) Cartridge Products Offered

7.6.5 BioDee Recent Development

7.7 Kanglang Biotechnology

7.7.1 Kanglang Biotechnology Company Information

7.7.2 Kanglang Biotechnology Business Overview

7.7.3 Kanglang Biotechnology Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Kanglang Biotechnology Activated Clotting Time (ACT) Cartridge Products Offered

7.7.5 Kanglang Biotechnology Recent Development

7.8 X-Y Biotechnology

7.8.1 X-Y Biotechnology Company Information

7.8.2 X-Y Biotechnology Business Overview

7.8.3 X-Y Biotechnology Activated Clotting Time (ACT) Cartridge Sales, Revenue and Gross Margin (2020-2025)

7.8.4 X-Y Biotechnology Activated Clotting Time (ACT) Cartridge Products Offered

7.8.5 X-Y Biotechnology Recent Development

8 Activated Clotting Time (ACT) Cartridge Manufacturing Cost Analysis

8.1 Activated Clotting Time (ACT) Cartridge Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Activated Clotting Time (ACT) Cartridge

8.4 Activated Clotting Time (ACT) Cartridge Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Activated Clotting Time (ACT) Cartridge Distributors List

9.3 Activated Clotting Time (ACT) Cartridge Customers

10 Activated Clotting Time (ACT) Cartridge Market Dynamics

10.1 Activated Clotting Time (ACT) Cartridge Industry Trends

10.2 Activated Clotting Time (ACT) Cartridge Market Drivers

10.3 Activated Clotting Time (ACT) Cartridge Market Challenges

10.4 Activated Clotting Time (ACT) Cartridge Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Activated Clotting Time (ACT) Cartridge Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Activated Clotting Time (ACT) Cartridge Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Activated Clotting Time (ACT) Cartridge Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Activated Clotting Time (ACT) Cartridge Sales (K Units) by Region (2020-2025)

Table 5. Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Region (2020-2025)

Table 6. Global Activated Clotting Time (ACT) Cartridge Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Region (2020-2025)

Table 8. Global Activated Clotting Time (ACT) Cartridge Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Activated Clotting Time (ACT) Cartridge Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Activated Clotting Time (ACT) Cartridge Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Activated Clotting Time (ACT) Cartridge Revenue Share Forecast by Region (2026-2031)

Table 12. Global Activated Clotting Time (ACT) Cartridge Sales by Type (K Units) & (2020-2025)

Table 13. Global Activated Clotting Time (ACT) Cartridge Sales Share by Type (2020-2025)

Table 14. Global Activated Clotting Time (ACT) Cartridge Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Activated Clotting Time (ACT) Cartridge Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Activated Clotting Time (ACT) Cartridge Sales by Type (K Units) & (2026-2031)

Table 17. Global Activated Clotting Time (ACT) Cartridge Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Activated Clotting Time (ACT) Cartridge Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Activated Clotting Time (ACT) Cartridge Sales by Application (K Units) & (2020-2025)

Table 21. Global Activated Clotting Time (ACT) Cartridge Sales Share by Application (2020-2025)

Table 22. Global Activated Clotting Time (ACT) Cartridge Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Activated Clotting Time (ACT) Cartridge Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Activated Clotting Time (ACT) Cartridge Sales by Application (K Units) & (2026-2031)

Table 25. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Activated Clotting Time (ACT) Cartridge Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Activated Clotting Time (ACT) Cartridge Application

Table 28. Global Activated Clotting Time (ACT) Cartridge Sales by Company (K Units) & (2020-2025)

Table 29. Global Activated Clotting Time (ACT) Cartridge Sales Share by Company (2020-2025)

Table 30. Global Activated Clotting Time (ACT) Cartridge Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Company (2020-2025)

Table 32. Global Activated Clotting Time (ACT) Cartridge by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activated Clotting Time (ACT) Cartridge as of 2024)

Table 33. Global Market Activated Clotting Time (ACT) Cartridge Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Activated Clotting Time (ACT) Cartridge, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Activated Clotting Time (ACT) Cartridge, Product Type & Application

Table 36. Global Key Manufacturers of Activated Clotting Time (ACT) Cartridge, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025) & (K Units)

Table 39. North America Activated Clotting Time (ACT) Cartridge Sales Market Share by Company (2020-2025)

Table 40. North America Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Activated Clotting Time (ACT) Cartridge Revenue Market Share by Company (2020-2025)

Table 42. North America Activated Clotting Time (ACT) Cartridge Sales by Type (2020-2025) & (K Units)

Table 43. North America Activated Clotting Time (ACT) Cartridge Sales Market Share by Type (2020-2025)

Table 44. North America Activated Clotting Time (ACT) Cartridge Sales by Application (2020-2025) & (K Units)

Table 45. North America Activated Clotting Time (ACT) Cartridge Sales Market Share by Application (2020-2025)

Table 46. Europe Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025) & (K Units)

Table 47. Europe Activated Clotting Time (ACT) Cartridge Sales Market Share by Company (2020-2025)

Table 48. Europe Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Activated Clotting Time (ACT) Cartridge Revenue Market Share by Company (2020-2025)

Table 50. Europe Activated Clotting Time (ACT) Cartridge Sales by Type (2020-2025) & (K Units)

Table 51. Europe Activated Clotting Time (ACT) Cartridge Sales Market Share by Type (2020-2025)

Table 52. Europe Activated Clotting Time (ACT) Cartridge Sales by Application (2020-2025) & (K Units)

Table 53. Europe Activated Clotting Time (ACT) Cartridge Sales Market Share by Application (2020-2025)

Table 54. China Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025) & (K Units)

Table 55. China Activated Clotting Time (ACT) Cartridge Sales Market Share by Company (2020-2025)

Table 56. China Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Activated Clotting Time (ACT) Cartridge Revenue Market Share by Company (2020-2025)

Table 58. China Activated Clotting Time (ACT) Cartridge Sales by Type (2020-2025) & (K Units)

Table 59. China Activated Clotting Time (ACT) Cartridge Sales Market Share by Type (2020-2025)

Table 60. China Activated Clotting Time (ACT) Cartridge Sales by Application (2020-2025) & (K Units)

Table 61. China Activated Clotting Time (ACT) Cartridge Sales Market Share by Application (2020-2025)

Table 62. Japan Activated Clotting Time (ACT) Cartridge Sales by Company (2020-2025) & (K Units)

Table 63. Japan Activated Clotting Time (ACT) Cartridge Sales Market Share by Company (2020-2025)

Table 64. Japan Activated Clotting Time (ACT) Cartridge Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Activated Clotting Time (ACT) Cartridge Revenue Market Share by Company (2020-2025)

Table 66. Japan Activated Clotting Time (ACT) Cartridge Sales by Type (2020-2025) & (K Units)

Table 67. Japan Activated Clotting Time (ACT) Cartridge Sales Market Share by Type (2020-2025)

Table 68. Japan Activated Clotting Time (ACT) Cartridge Sales by Application (2020-2025) & (K Units)

Table 69. Japan Activated Clotting Time (ACT) Cartridge Sales Market Share by Application (2020-2025)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Activated Clotting Time (ACT) Cartridge Product

Table 74. Medtronic Recent Development

Table 75. Abbott Company Information

Table 76. Abbott Description and Business Overview

Table 77. Abbott Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Abbott Activated Clotting Time (ACT) Cartridge Product

Table 79. Abbott Recent Development

Table 80. Calbiotech Company Information

Table 81. Calbiotech Description and Business Overview

Table 82. Calbiotech Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Calbiotech Activated Clotting Time (ACT) Cartridge Product

Table 84. Calbiotech Recent Development

Table 85. Anogen Company Information

Table 86. Anogen Description and Business Overview

Table 87. Anogen Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Anogen Activated Clotting Time (ACT) Cartridge Product

Table 89. Anogen Recent Development

Table 90. Sienco Company Information

Table 91. Sienco Description and Business Overview

Table 92. Sienco Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Sienco Activated Clotting Time (ACT) Cartridge Product

Table 94. Sienco Recent Development

Table 95. BioDee Company Information

Table 96. BioDee Description and Business Overview

Table 97. BioDee Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. BioDee Activated Clotting Time (ACT) Cartridge Product

Table 99. BioDee Recent Development

Table 100. Kanglang Biotechnology Company Information

Table 101. Kanglang Biotechnology Description and Business Overview

Table 102. Kanglang Biotechnology Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Kanglang Biotechnology Activated Clotting Time (ACT) Cartridge Product

Table 104. Kanglang Biotechnology Recent Development

Table 105. X-Y Biotechnology Company Information

Table 106. X-Y Biotechnology Description and Business Overview

Table 107. X-Y Biotechnology Activated Clotting Time (ACT) Cartridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. X-Y Biotechnology Activated Clotting Time (ACT) Cartridge Product

Table 109. X-Y Biotechnology Recent Development

Table 110. Production Base and Market Concentration Rate of Raw Material

Table 111. Key Suppliers of Raw Materials

Table 112. Activated Clotting Time (ACT) Cartridge Distributors List

Table 113. Activated Clotting Time (ACT) Cartridge Customers List

Table 114. Activated Clotting Time (ACT) Cartridge Market Trends

Table 115. Activated Clotting Time (ACT) Cartridge Market Drivers

Table 116. Activated Clotting Time (ACT) Cartridge Market Challenges

Table 117. Activated Clotting Time (ACT) Cartridge Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Activated Clotting Time (ACT) Cartridge Product Picture

Figure 2. Global Activated Clotting Time (ACT) Cartridge Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Type in 2024 & 2031

Figure 4. Enzyme-linked Immunosorbent Assay Product Picture

Figure 5. Coagulation Method Product Picture

Figure 6. Others Product Picture

Figure 7. Global Activated Clotting Time (ACT) Cartridge Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Application in 2024 & 2031

Figure 9. Hospital Examples

Figure 10. Clinic Examples

Figure 11. Others Examples

Figure 12. Global Activated Clotting Time (ACT) Cartridge Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Activated Clotting Time (ACT) Cartridge Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Activated Clotting Time (ACT) Cartridge Sales (K Units) Growth Rate (2020-2031)

Figure 15. Global Activated Clotting Time (ACT) Cartridge Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 16. Activated Clotting Time (ACT) Cartridge Report Years Considered

Figure 17. Global Market Activated Clotting Time (ACT) Cartridge Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Activated Clotting Time (ACT) Cartridge Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Activated Clotting Time (ACT) Cartridge Sales (K Units) Growth Rate (2020-2031)

Figure 21. Europe Activated Clotting Time (ACT) Cartridge Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Activated Clotting Time (ACT) Cartridge Sales (K Units) Growth Rate (2020-2031)

Figure 23. China Activated Clotting Time (ACT) Cartridge Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Activated Clotting Time (ACT) Cartridge Sales (K Units) Growth Rate (2020-2031)

Figure 25. Japan Activated Clotting Time (ACT) Cartridge Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Japan Activated Clotting Time (ACT) Cartridge Sales (K Units) Growth Rate (2020-2031)

Figure 27. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Type (2020-2025)

Figure 28. Global Activated Clotting Time (ACT) Cartridge Sales Share by Type (2026-2031)

Figure 29. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Type (2026-2031)

Figure 30. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Application (2020-2025)

Figure 31. Global Activated Clotting Time (ACT) Cartridge Revenue Growth Rate by Application in 2020 & 2024

Figure 32. Global Activated Clotting Time (ACT) Cartridge Sales Share by Application (2026-2031)

Figure 33. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Application (2026-2031)

Figure 34. Global Activated Clotting Time (ACT) Cartridge Sales Share by Company (2024)

Figure 35. Global Activated Clotting Time (ACT) Cartridge Revenue Share by Company (2024)

Figure 36. Global 5 Largest Activated Clotting Time (ACT) Cartridge Players Market Share by Revenue in Activated Clotting Time (ACT) Cartridge: 2020 & 2024

Figure 37. Activated Clotting Time (ACT) Cartridge Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Manufacturing Cost Structure of Activated Clotting Time (ACT) Cartridge

Figure 39. Manufacturing Process Analysis of Activated Clotting Time (ACT) Cartridge

Figure 40. Activated Clotting Time (ACT) Cartridge Industrial Chain

Figure 41. Channels of Distribution (Direct Vs Distribution)

Figure 42. Distributors Profiles

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Activated Clotting Time (ACT) Cartridge market? zhanKai

The top companies in the global Activated Clotting Time (ACT) Cartridge market are Medtronic、Abbott、Calbiotech.

Related Reports

Global Activated Clotting Time (ACT) Cartridge Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 146
USD 4900.00
(Single User License)
Global Activated Clotting Time (ACT) Cartridge Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Activated Clotting Time (ACT) Cartridge market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 78
USD 4250.00
(Single User License)
Activated Clotting Time (ACT) Cartridge- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Activated Clotting Time (ACT) Cartridge was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 100
USD 3950.00
(Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Research Report 2026
The global Activated Clotting Time (ACT) Cartridge market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 110
USD 2900.00
(Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 133
USD 4900.00
(Single User License)
Activated Clotting Time (ACT) Cartridge - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Activated Clotting Time (ACT) Cartridge was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Research Report 2025
The global market for Activated Clotting Time (ACT) Cartridge was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 85
USD 2900.00
(Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Insights, Forecast to 2030
The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-05-22
Pages: 138
USD 4900.00
(Single User License)
Global and United States Activated Clotting Time (ACT) Cartridge Market Report & Forecast 2024-2030
The global Activated Clotting Time (ACT) Cartridge revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-05-14
Pages: 119
USD 4350.00
(Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Research Report 2024
The global Activated Clotting Time (ACT) Cartridge market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-05-14
Pages: 86
USD 2900.00
(Single User License)

Global Activated Clotting Time (ACT) Cartridge Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 146
USD 4900.00 (Single User License)
Global Activated Clotting Time (ACT) Cartridge Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Activated Clotting Time (ACT) Cartridge market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 78
USD 4250.00 (Single User License)
Activated Clotting Time (ACT) Cartridge- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Activated Clotting Time (ACT) Cartridge was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 100
USD 3950.00 (Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Research Report 2026
The global Activated Clotting Time (ACT) Cartridge market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 110
USD 2900.00 (Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 133
USD 4900.00 (Single User License)
Activated Clotting Time (ACT) Cartridge - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Activated Clotting Time (ACT) Cartridge was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
USD 3950.00 (Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Research Report 2025
The global market for Activated Clotting Time (ACT) Cartridge was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 85
USD 2900.00 (Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Insights, Forecast to 2030
The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-05-22
Pages: 138
USD 4900.00 (Single User License)
Global and United States Activated Clotting Time (ACT) Cartridge Market Report & Forecast 2024-2030
The global Activated Clotting Time (ACT) Cartridge revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-05-14
Pages: 119
USD 4350.00 (Single User License)
Global Activated Clotting Time (ACT) Cartridge Market Research Report 2024
The global Activated Clotting Time (ACT) Cartridge market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-05-14
Pages: 86
USD 2900.00 (Single User License)